![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review](https://benthamopen.com/contents/figures/TOPAINJ/TOPAINJ-13-7_F1.jpg)
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
![Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System](https://www.frontiersin.org/files/Articles/856672/fphar-13-856672-HTML/image_m/fphar-13-856672-g001.jpg)
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
![Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling](https://www.science.org/cms/10.1126/scisignal.aai8441/asset/46ae1e57-be51-4561-8c82-fec4afe7f398/assets/graphic/9_ra117_f5.jpeg)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Pharmacodynamic Considerations for Moderate and Deep Sedation | American Dental Society of Anesthesiology
Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse Effects | Journal of Medicinal Chemistry
![Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review | Semantic Scholar Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb92ed98906c4d68253daec6b23587fc2a5e4547/2-Table1-1.png)
Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review | Semantic Scholar
![Sedation quality of alfaxalone associated with butorphanol, methadone or pethidine in cats injected into the supraspinatus or the quadriceps muscle - Giacomo Giannettoni, Giulia Moretti, Laura Menchetti, Arianna Pepe, Federica Bellocchi, Antonello Sedation quality of alfaxalone associated with butorphanol, methadone or pethidine in cats injected into the supraspinatus or the quadriceps muscle - Giacomo Giannettoni, Giulia Moretti, Laura Menchetti, Arianna Pepe, Federica Bellocchi, Antonello](https://journals.sagepub.com/cms/10.1177/1098612X221104747/asset/images/large/10.1177_1098612x221104747-fig4.jpeg)
Sedation quality of alfaxalone associated with butorphanol, methadone or pethidine in cats injected into the supraspinatus or the quadriceps muscle - Giacomo Giannettoni, Giulia Moretti, Laura Menchetti, Arianna Pepe, Federica Bellocchi, Antonello
![An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661822000366-ga1.jpg)
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
![Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006899318304888-gr2.jpg)